Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 04 2023
Historique:
received: 20 05 2022
accepted: 20 04 2023
medline: 17 5 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

Genome-wide association studies (GWAS) have contributed to our understanding of glioma susceptibility. To date, 25 risk loci for development of any of the glioma subtypes are known. However, GWAS studies reveal little about the molecular processes that lead to increased risk, especially for non-coding single nucleotide polymorphisms (SNP). A particular SNP in intron 2 of LRIG1, rs11706832, has been shown to increase the susceptibility for IDH1 mutated low-grade gliomas (LGG). Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is important in cancer development as it negatively regulates the epidermal growth factor receptor (EGFR); however, the mechanism responsible for this particular risk SNP and its potential effect on LRIG1 are not known. Using CRISPR-CAS9, we edited rs11706832 in HEK293T cells. Four HEK293T clones with the risk allele were compared to four clones with the non-risk allele for LRIG1 and SLC25A26 gene expression using RT-qPCR, for global gene expression using RNA-seq, and for metabolites using gas chromatography-mass spectrometry (GC-MS). The experiment did not reveal any significant effect of the SNP on the expression levels or splicing patterns of LRIG1 or SLC25A26. The global gene expression analysis revealed that the risk allele C was associated with upregulation of several mitochondrial genes. Gene enrichment analysis of 74 differentially expressed genes in the genome revealed a significant enrichment of type I interferon response genes, where many genes were downregulated for the risk allele C. Gene expression data of IDH1 mutated LGGs from the cancer genome atlas (TCGA) revealed a similar under expression of type I interferon genes associated with the risk allele. This study found the expression levels and splicing patterns of LRIG1 and SLC25A26 were not affected by the SNP in HEK293T cells. However, the risk allele was associated with a downregulation of genes involved in the innate immune response both in the HEK293T cells and in the LGG data from TCGA.

Identifiants

pubmed: 37185361
doi: 10.1038/s41598-023-33923-4
pii: 10.1038/s41598-023-33923-4
pmc: PMC10130147
doi:

Substances chimiques

Membrane Glycoproteins 0
Interferon Type I 0
SLC25A26 protein, human 0
Calcium-Binding Proteins 0
Amino Acid Transport Systems 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6777

Informations de copyright

© 2023. The Author(s).

Références

J Zhejiang Univ Sci B. 2021 Aug 15;22(8):609-632
pubmed: 34414698
FEBS J. 2017 Mar;284(6):967-984
pubmed: 28118529
Neuro Oncol. 2021 Apr 12;23(4):638-649
pubmed: 33130899
Biochem Biophys Res Commun. 2001 Jun 29;284(5):1155-61
pubmed: 11414704
Sci Rep. 2015 Dec 02;5:17267
pubmed: 26625949
Cancers (Basel). 2019 Dec 12;11(12):
pubmed: 31842352
Nat Commun. 2021 May 10;12(1):2594
pubmed: 33972529
J Biol Chem. 2018 Mar 2;293(9):3421-3435
pubmed: 29317492
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Rev Immunol. 2017 Jun;17(6):363-375
pubmed: 28393922
Oncogenesis. 2018 Feb 2;7(2):13
pubmed: 29391393
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
BMC Cancer. 2020 Jun 19;20(1):575
pubmed: 32560641
Br J Cancer. 2020 Jan;122(2):221-232
pubmed: 31819184
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Neuro Oncol. 2022 Sep 1;24(9):1454-1468
pubmed: 35157758
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Interferon Cytokine Res. 1998 Sep;18(9):767-71
pubmed: 9781816
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96
pubmed: 33123732
Am J Hum Genet. 2015 Nov 5;97(5):761-8
pubmed: 26522469
Int J Cancer. 1999 May 5;81(3):366-70
pubmed: 10209950
Science. 2022 Oct 7;378(6615):68-78
pubmed: 36201590
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Front Mol Biosci. 2019 Dec 19;6:148
pubmed: 31921891
Int J Biol Sci. 2013;9(2):200-8
pubmed: 23459883
Int J Cancer. 2016 Aug 1;139(3):491-500
pubmed: 26874464
BMC Cancer. 2020 May 24;20(1):459
pubmed: 32448168
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Biochimie. 2007 Jun-Jul;89(6-7):779-88
pubmed: 17408844
J Cell Sci. 2007 May 1;120(Pt 9):1646-53
pubmed: 17452626
Nat Genet. 2017 May;49(5):789-794
pubmed: 28346443
Front Immunol. 2021 Apr 27;12:667454
pubmed: 33986756
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Neurosurg Focus. 2015 Jan;38(1):E6
pubmed: 25552286
EMBO J. 2004 Aug 18;23(16):3270-81
pubmed: 15282549
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Nat Rev Immunol. 2008 Nov;8(11):849-60
pubmed: 18836477

Auteurs

Adam Rosenbaum (A)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden. adam.rosenbaum@umu.se.

Anna M Dahlin (AM)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.

Ulrika Andersson (U)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.

Benny Björkblom (B)

Department of Chemistry, Umeå University, Umeå, Sweden.

Wendy Yi-Ying Wu (WY)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.

Håkan Hedman (H)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.

Carl Wibom (C)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.

Beatrice Melin (B)

Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH